An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
Corrigendum to: iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Lin et al. [1] would like to correct Fig. 4B as errors were introduced in the preparation of these figures for publication. The authors were able to provide to the journal the raw data underlying all experimental replicates. The journal has reviewed replicate raw data and the Editors and Authors confirm that correction of this error has not altered the interpretation of data and did not affect the conclusions presented in the article. The authors sincerely apologise for their mistake and for any inconvenience caused.
The corrected figures are reproduced below. Figure 4B: Corrected to match the correct raw data files. Initially, a different image was shown in panel B for the sw480LOHP mock condition.
Reference
1.
Lin D, Zhang H, Liu R, Deng T, Ning T, Bai M, et al. iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Mol Oncol. 2021;15:3430–46. 10.1002/1878-0261.13052
[DOI] [PMC free article] [PubMed] [Google Scholar]